Krsnaa Diagnostics per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹30.06₹31.30₹24.04₹17.90₹19.78
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹29.65₹30.88₹23.56₹17.31₹19.29
₹302.23₹302.23₹273.39₹250.79₹235.28
₹251.35₹238.23₹222.10₹191.90₹155.14
—₹44.11₹27.04₹7.54₹24.30
−₹23.48−₹23.48−₹12.17−₹52.51−₹20.72
—₹2.75₹2.50₹2.67₹2.50
3.23.23.23.23.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

KRSNAA₹497.95

Krsnaa Diagnostics Limited

· Pharma & Health
₹ CrorePeersSURAKSHAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,615 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS19.7817.9024.0431.3030.06
Diluted EPS19.2917.3123.5630.8829.65
Book Value per Share235.28250.79273.39302.23302.23
Revenue per Share155.14191.90222.10238.23251.35
Cash Flow per Share24.307.5427.0444.11—
Free Cash Flow per Share-20.72-52.51-12.17-23.48-23.48
Dividends per Share2.502.672.502.75—
Shares Outstanding (cr)3.13.23.23.23.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.